Skip to content
Equator Therapeutics logo

Equator Therapeutics

Equator Therapeutics is a YC Winter 2020 (W20) company. Based in San Francisco, CA, USA. Team of 2.

  • Biotech
  • Therapeutics

About Equator Therapeutics

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Equator Therapeutics develops a first-in-class drug to treat obesity and type 2 diabetes by pharmacologically activating thermogenesis, the body's natural calorie-burning heat production. The company identified the mitochondrial protein responsible for heat generation and built a high-throughput platform to find compounds that selectively activate it. The drug is intended to replicate the metabolic effect of exercise without requiring physical activity, replacing the limited efficacy of current diet and exercise-based interventions.

From the Y Combinator listing

How Equator Therapeutics describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

We are developing a drug to burn calories and increase metabolism…

We are developing a drug to increase metabolism and burn calories without exercise. Obesity and type 2 diabetes have reached epidemic proportions. There are 2.2B overweight people and 500M people with type 2 diabetes worldwide, and these numbers increase drastically every year. Existing drugs are not effective enough to reverse the trend. Our drug can solve this problem, because it addresses the root cause of metabolic disorders – the imbalance between caloric intake and expenditure. Our drug will target mitochondria – the powerhouse of the cell – to generate heat. This approach has been proven to fully reverse obesity and type 2 diabetes in animals. However, therapeutic application for humans was impossible, because mitochondrial heat production could only be induced by highly artificial methods with side effects. This changed after our recent breakthrough discovery of the protein that mitochondria naturally use to generate heat. We have developed a unique high-throughput drug discovery platform to identify compounds that selectively activate this target protein, without side effects. For decades people have wanted a drug that burns calories like exercise does. We are realizing this dream at Equator Therapeutics.

Facts

Industry
Healthcare / Healthcare -> Therapeutics
Location
San Francisco, CA, USA
Team size
2
Status
Active
Stage
Early

Founders (3)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works